Director Fahed Al-Marzooqi (VTVT) granted 6,000 vTv Therapeutics stock options
Rhea-AI Filing Summary
vTv Therapeutics Inc. director Fahed Al-Marzooqi received a grant of stock options covering 6,000 shares of Class A common stock at an exercise price of $35.08 per share. These options vest on the earlier of June 26, 2027 and the 2027 annual general meeting of shareholders, conditioned on continued board service, and expire on June 26, 2036. Following this grant, his reported derivative holdings tied to this award total 19,555 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Al-Marzooqi Fahed
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director stock option (right to buy) | 6,000 | $35.08 | $210K |
Holdings After Transaction:
Director stock option (right to buy) — 19,555 shares (Direct)
Footnotes (1)
- F1. The option vests on the earlier of June 26, 2027, and the date of the 2027 annual general meeting of shareholders, subject to the director's continued service on the board of directors through such vesting.
Key Figures
Option grant size: 6,000 options
Exercise price: $35.08 per share
Expiration date: June 26, 2036
+2 more
5 metrics
Option grant size
6,000 options
Director stock option grant on June 26, 2026
Exercise price
$35.08 per share
Director stock option exercise price
Expiration date
June 26, 2036
Option term end date
Total derivative holdings after grant
19,555 options
Reported following transaction
Vesting date trigger
Earlier of June 26, 2027 or 2027 AGM
Vesting condition subject to continued board service
Key Terms
Director stock option (right to buy), exercise price, vesting, annual general meeting of shareholders
4 terms
Director stock option (right to buy) financial
"Director stock option (right to buy) with 6,000 underlying shares"
exercise price financial
"An exercise price of $35.08 per share applies to the options"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests on the earlier of June 26, 2027, and the date of the 2027 annual general meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did vTv Therapeutics (VTVT) director Fahed Al-Marzooqi receive in this Form 4 filing?
Director Fahed Al-Marzooqi received a grant of stock options covering 6,000 shares of vTv Therapeutics Class A common stock. The options are part of his director compensation and give him the right to buy shares at a fixed exercise price of $35.08.
What is the exercise price and term of Fahed Al-Marzooqi’s vTv Therapeutics options?
The granted director stock options have an exercise price of $35.08 per share and expire on June 26, 2036. This long term gives the director a multi-year window to decide whether to exercise the options, subject to vesting conditions.
When do Fahed Al-Marzooqi’s vTv Therapeutics director stock options vest?
The options vest on the earlier of June 26, 2027 and the date of vTv Therapeutics’ 2027 annual general meeting of shareholders. Vesting is subject to his continued service on the board of directors through that vesting date.
How many vTv Therapeutics derivative securities does Fahed Al-Marzooqi hold after this grant?
After the grant, the Form 4 reports total derivative holdings of 19,555 options related to vTv Therapeutics Class A common stock. This figure reflects his position following the 6,000-share director stock option award disclosed in the transaction.
Is Fahed Al-Marzooqi’s vTv Therapeutics Form 4 transaction a market purchase or sale?
The Form 4 shows a grant coded “A,” meaning a grant, award, or other acquisition from the company, not an open-market trade. It represents compensation in the form of stock options rather than buying or selling shares in the market.